NOC
58
4
MPC
36
-2
NUE
54
-4
SJM
14
2
NWSA
79
15
IP
34
6
WM
60
3
LMT
62
3
ETR
49
2
SE
54
5
CME
52
7
WU
38
-9
AEE
55
4
FOXA
66
2
LEN
21
-9
CHRW
79
-3
CI
52
4
GRMN
45
8
MHK
45
2
FTI
64
-5
NOC
58
4
MPC
36
-2
NUE
54
-4
SJM
14
2
NWSA
79
15
IP
34
6
WM
60
3
LMT
62
3
ETR
49
2
SE
54
5
CME
52
7
WU
38
-9
AEE
55
4
FOXA
66
2
LEN
21
-9
CHRW
79
-3
CI
52
4
GRMN
45
8
MHK
45
2
FTI
64
-5
Financhill
Back

UroGen Pharma Ltd. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26

URGN
UroGen Pharma Ltd.

Last Price:
$23.55
Seasonality Move:
-2.48%

7 Day Trial

ALL ACCESS PASS

$ 7

UroGen Pharma Ltd. Stock Forecast

  • Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.3% based on the past 8 years of stock performance.
  • UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is UroGen Pharma Ltd. Stock Undervalued?
    The current UroGen Pharma Ltd. [URGN] share price is $23.58. The Score for URGN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Ltd. Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.3% based on the past 8 years of stock performance.

UroGen Pharma Ltd. Stock Rating

Sell
26
UroGen Pharma Ltd. (URGN) is a Sell

Is UroGen Pharma Ltd. overpriced?

  • UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

UroGen Pharma Ltd. Stock Price History

Is URGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URGN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
30.00
52-Week Low:
3.42

Prediction Charts

Market Cap:
1.1B
Price in USD:
23.58
Volume:
817.9K
Beta:
1.30

Technical Analysis

SMA50:
22.23
SMA100:
20.50
SMA200:
15.87
52-Wk Change:
121.62%

Stock Predictions

  • Is UroGen Pharma Ltd. stock public?
    Yes, UroGen Pharma Ltd. is a publicly traded company.
  • What is the UroGen Pharma Ltd. stock quote today?
    The UroGen Pharma Ltd. stock price is 23.58 USD today.
  • How to buy UroGen Pharma Ltd. stock online?
    You can buy UroGen Pharma Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 24.50 24.35 25.83 24.27
Dec-4 24.42 24.28 24.92 23.92
Dec-5 23.77 22.98 24.65 22.51
Dec-8 23.37 23.08 23.74 22.82
Dec-9 23.15 22.70 23.56 22.67
Dec-10 22.74 22.19 23.24 22.11
Dec-11 22.35 22.36 22.62 21.74
Dec-12 22.38 21.80 22.66 21.78
Dec-15 21.90 22.85 22.92 21.40
Dec-16 22.88 23.47 24.71 22.88
Dec-17 23.44 22.62 23.80 22.42
Dec-18 22.72 21.72 22.93 21.62
Dec-19 21.92 22.80 23.20 21.72
Dec-22 23.00 23.58 24.04 22.79

UroGen Pharma Ltd. Earnings

UroGen Pharma Ltd. Earnings Report: Per Share UroGen Pharma Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Ltd. Forecast Revenue Growth

UroGen Pharma Ltd. Stock Analysis: Historical quarterly revenues per share for UroGen Pharma Ltd. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $2.53 per share.

* UroGen Pharma Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.